IN
Indivior Pharmaceuticals Inc (INDV)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$40.42
-1.37%
Mkt Cap $5.05B
Analyst Ratings
No recent rating data.
Price Target (14 analysts)
$48.00
Range $46.00 – $50.00
Implied Upside
+18.8%
Consensus $48.00 vs current $40.42